Biofourmis competitors

Zippia score 4.1

Competitor Summary. See how Biofourmis compares to its main competitors:

Pear Therapeutics has the most employees (180).
The oldest company is Rimidi, founded in 2012.

Work at Biofourmis?

Share your experience

Biofourmis vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
Biofourmis	2015	4.1	Boston, MA	1	$6.0M	144
Bloomlife	2014	4.2	San Francisco, CA	1	$7.0M	28
Pear Therapeutics	2013	4.4	Boston, MA	2	$20.0M	180
SpIntellx	2017	3.3	Pittsburgh, PA	1	$87,000	6
CAMP4 Therapeutics	2016	3.9	Cambridge, MA	1	$890,000	46
Rimidi	2012	3.7	Atlanta, GA	1	$1.0M	22
OneThree Biotech	2018	3.5	New York, NY	1	$130,000	7

Rate how well Biofourmis differentiates itself from its competitors.

Biofourmis salaries vs competitors

Compare Biofourmis salaries vs competitors

Company	Average salary	Hourly salary	Salary score
Biofourmis	$118,812	$57.12	-

Compare Biofourmis job title salaries vs competitors

Company	Highest salary	Hourly salary
Biofourmis	$110,947	$53.34
SpIntellx	$111,095	$53.41
OneThree Biotech	$111,092	$53.41
Rimidi	$111,087	$53.41
CAMP4 Therapeutics	$111,016	$53.37
Bloomlife	$111,012	$53.37
Pear Therapeutics	$110,832	$53.28

Do you work at Biofourmis?

Does Biofourmis effectively differentiate itself from competitors?

Biofourmis jobs

Biofourmis demographics vs competitors

Compare gender at Biofourmis vs competitors

Job title	Male	Female
Pear Therapeutics	39%	61%
Biofourmis	-	-

Male

Female

100%

75%

50%

25%

Biofourmis

Pear Therapeutics

25%

50%

75%

100%

Compare race at Biofourmis vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
Pear Therapeutics	62%	14%	12%	9%	4%	9.7

Biofourmis and similar companies CEOs

CEOBio

Josh Claman

Rimidi

Josh Claman is a Chief Executive Officer at Rimidi and is based in Austin Texas Area. He has worked as VP / GM Dell UK / Ireland at Dell; Vice President Public Sector, Dell EMEA at Dell; and Vice President at NCR Corporation. Josh studied at Saïd Business School, University of Oxford between 1996 and 1996; University of Illinois between 1979 and 1982; and University of South Carolina.

Chakra Chennubhotla

SpIntellx

Chennubhotla is currently an Associate Professor in the Department of Computational and Systems Biology at the University of Pittsburgh. Chennubhotla leads the campus-wide effort in computational systems pathology at Pitt, with active participation of collaborators from both academia and industry. His group's primary research focus is in building machine learning and systems biology algorithms to discover the mechanistic basis of disease progression (metastasis) from in-situ imaging data. Chakra moved from industry to academia to pursue his Ph.D. at the University of Toronto in the Department of Computer Science, specializing in computer vision and machine learning for high-dimensional perceptual data.

Neel S. Madhukar

OneThree Biotech